InformerNow

People with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of beginning immunotherapy lived considerably longer than those who did not, according to new research. Scientists from the University of Florida and the University of Texas MD Anderson Cancer Center describe this as a milestone in more than a…

Men whose prostate cancer returns after surgery or radiation therapy may soon benefit from a powerful new treatment that has been shown in clinical trials to reduce the risk of death by more than 40%. Researchers tested a therapy that combines enzalutamide, an existing cancer drug, with standard hormone therapy. This approach significantly lowered death…

Scientists at the Francis Crick Institute and Vividion Therapeutics have discovered chemical compounds that can precisely prevent the cancer-driving gene RAS from connecting with a key pathway responsible for tumor growth. The potential treatment is now moving into its first human clinical trial. If proven safe and effective, it could become a way to treat…

Scientists at Johns Hopkins University may have uncovered a promising clue in the long-running effort to confirm the existence of dark matter. For years, astronomers have puzzled over a faint, widespread glow of gamma rays near the Milky Way’s center. The source of this mysterious light has remained uncertain, leaving two main possibilities: it could…

A large-scale investigation has found that people who regularly consume both sugar-sweetened beverages (SSBs) and low- or no-sugar-sweetened beverages (LNSSBs) face a significantly greater likelihood of developing metabolic dysfunction-associated steatotic liver disease (MASLD).1 Presented at UEG Week 2025, the research followed 123,788 adults from the UK Biobank who had no signs of liver disease at…

How did the universe come into existence, and what early processes shaped everything that followed? A new study published in Physical Review Research takes aim at this fundamental question. Scientists from Spain and Italy have introduced a model that reimagines what happened moments after the universe was born. Their approach could upend long-standing ideas about…

For nearly ten years, the Stanford Brain Organogenesis Program has been redefining how scientists study the human brain. Instead of relying on intact brain tissue from humans or animals, researchers in the program grow three-dimensional brain-like structures in the lab using stem cells. These tiny models, called human neural organoids and assembloids, allow scientists to…